FDA Clearance Tracker · P090013-S313
CapSureFix MRI Lead
Last checked: Nov 20, 2026Latest source record: Dec 22, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Dec 22, 2020
Approved
Time to decision
19 days
Received Dec 3, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P090013-S313
- Device name
- CapSureFix MRI Lead
- Applicant
- Medtronic, Inc.
- Applicant location
- Mounds View, MN
- Received
- Dec 3, 2020
- Decided
- Dec 22, 2020
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P090013
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Manufacturing site located at Medtronic Singapore Operations: 49 Changi South Avenue 2, Nasaco Tech Centre, Singapore 486056.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
K262913 · Decided Sep 17, 2026 · 29 days after receipt
Device type: Stents, Drains And Dilators For The Biliary Ducts (FGE) · GI, Urology & Nephrology
K262735 · Decided Aug 28, 2026 · 28 days after receipt
Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.